Effect of an electronic alert on risk of contrast-induced acute kidney injury in hospitalized patients undergoing computed tomography.

BACKGROUND Prophylaxis against contrast-induced acute kidney injury (AKI) in hospitalized patients is underused. We evaluated the impact of a computerized alert program for contrast-induced AKI for hospitalized patients undergoing contrast-enhanced computed tomography (CT). STUDY DESIGN Quality improvement report. SETTING & PARTICIPANTS 463 adult inpatients in a single center with estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m(2). QUALITY IMPROVEMENT PLAN We developed a computer alert program in which the responsible physician was alerted to a patient's risk of contrast-induced AKI in the form of a warning message box and was recommended to consider prophylactic measures for contrast-induced AKI when he or she ordered contrast-enhanced CT for patients with eGFR <60 mL/min/1.73 m(2). The intervention was applied simultaneously to all hospitalized patients from March 18, 2010. The hospital's contrast-induced AKI preventive guidelines included prehydration, posthydration, and oral N-acetylcysteine. OUTCOME & MEASUREMENTS Use of prophylactic interventions, development of contrast-induced AKI. Contrast-induced AKI was defined as an increase in serum creatinine level (≥0.3 mg/dL or ≥50%) 24-72 hours after contrast medium exposure. RESULTS 258 adult inpatients with eGFR <60 mL/min/1.73 m(2) were identified as undergoing contrast-enhanced CT before application of the computer alert program (from October 28, 2009, to March 17, 2010), and 205, after its application (from March 18, 2010, to August 5, 2010). Individuals in the postalert group received contrast-induced AKI prophylaxis more often than those in the prealert group (55% vs 25% for total prophylaxis; P < 0.001). The incidence of contrast-induced AKI was lower in the postalert group than in the prealert group (3% vs 10%; P = 0.02). LIMITATIONS Observation bias; only 61.5% of participants were evaluated for contrast-induced AKI. CONCLUSIONS Implementation of a computerized alert program in hospitalized patients was followed by increased use of prophylaxis and decreased risk of contrast-induced AKI.

[1]  D. Sahani,et al.  Erratum: Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: A double-blind comparison of iodixanol and iopamidol (Investigative Radiology (2006) 41, (815821)) , 2007 .

[2]  G. Kuperman,et al.  Computer Physician Order Entry: Benefits, Costs, and Issues , 2003, Annals of Internal Medicine.

[3]  S. Weisbord,et al.  Prevention of contrast-induced nephropathy with volume expansion. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[4]  P. McCullough,et al.  Contrast-induced acute kidney injury. , 2018, Journal of the American College of Cardiology.

[5]  S. Goldfarb,et al.  Contrast-induced acute kidney injury: specialty-specific protocols for interventional radiology, diagnostic computed tomography radiology, and interventional cardiology. , 2009, Mayo Clinic proceedings.

[6]  R. Garrick.  Contrast-Induced Nephropathy After Percutaneous Coronary Interventions in Relation to Chronic Kidney Disease and Hemodynamic Variables , 2007 .

[7]  J. Tumlin,et al.  Economic burden of contrast-induced nephropathy: implications for prevention strategies , 2007, Journal of medical economics.

[8]  S. Anderson,et al.  Intravenous N-Acetylcysteine in the Prevention of Contrast Media-Induced Nephropathy , 2011, The Annals of pharmacotherapy.

[9]  S. Marsch,et al.  Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. , 2002, Archives of internal medicine.

[10]  Pierre Durieux,et al.  Electronic medical alerts--so simple, so complex. , 2005, The New England journal of medicine.

[11]  K. Harjai,et al.  Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. , 2004, The American journal of cardiology.

[12]  R. Bersin,et al.  Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. , 2004, JAMA.

[13]  William L. Galanter,et al.  Application of Information Technology: A Trial of Automated Decision Support Alerts for Contraindicated Medications Using Computerized Physician Order Entry , 2005, J. Am. Medical Informatics Assoc..

[14]  W. O’Neill,et al.  Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. , 1997, The American journal of medicine.

[15]  Jeremiah R. Brown,et al.  How do centres begin the process to prevent contrast-induced acute kidney injury: a report from a new regional collaborative , 2011, BMJ quality & safety.

[16]  A. Agrawal,et al.  A Randomized Prospective Trial to Assess the Role of Saline Hydration on the Development of Contrast Nephrotoxicity , 2003, Nephron Clinical Practice.

[17]  The Origin trial investigators.  Rationale, design, and baseline characteristics of the Acetylcystein for Contrast-Induced nephropaThy (ACT) Trial: a pragmatic randomized controlled trial to evaluate the efficacy of acetylcysteine for the prevention of contrast-induced nephropathy , 2009, Trials.

[18]  A. Einstein,et al.  Estimating risk of cancer associated with radiation exposure from 64-slice computed tomography coronary angiography. , 2007, JAMA.

[19]  Act Investigators.  Acetylcysteine for Prevention of Renal Outcomes in Patients Undergoing Coronary and Peripheral Vascular Angiography: Main Results From the Randomized Acetylcysteine for Contrast-Induced Nephropathy Trial (ACT) , 2011, Circulation.

[20]  U. Erkorkmaz,et al.  Intravenous N-acetylcysteine plus high-dose hydration versus high-dose hydration and standard hydration for the prevention of contrast-induced nephropathy: CASIS--a multicenter prospective controlled trial. , 2012, International journal of cardiology.

[21]  M. Fine,et al.  Incidence and outcomes of contrast-induced AKI following computed tomography. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[22]  Allison B McCoy,et al.  A computerized provider order entry intervention for medication safety during acute kidney injury: a quality improvement report. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[23]  C. McDonald,et al.  A computerized reminder system to increase the use of preventive care for hospitalized patients. , 2001, The New England journal of medicine.

[24]  N. Lameire.  Contrast-induced nephropathy--prevention and risk reduction. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[25]  Toshihisa Hirai,et al.  Does N-acetylcysteine reduce the incidence of contrast-induced nephropathy and clinical events in patients undergoing primary angioplasty for acute myocardial infarction? , 2011, Internal medicine.

[26]  P. Parfrey,et al.  Preventing Nephropathy Induced by Contrast Medium , 2006 .

[27]  J. D'Elia,et al.  Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. , 1994, The New England journal of medicine.

[28]  K. Kent,et al.  Percutaneous coronary intervention‐associated nephropathy foreshadows increased risk of late adverse events in patients with normal baseline serum creatinine , 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[29]  M. Tonelli,et al.  Prophylaxis strategies for contrast-induced nephropathy. , 2006, JAMA.

[30]  A. Schoenfeld,et al.  Radiocontrast-associated renal dysfunction: incidence and risk factors. , 1991, AJR. American journal of roentgenology.

[31]  Omer Toprak.  Conflicting and new risk factors for contrast induced nephropathy. , 2007, The Journal of urology.

[32]  P. Albertsen.  Guided medication dosing for inpatients with renal insufficiency. , 2002, The Journal of urology.

[33]  M. Fine,et al.  Associations of increases in serum creatinine with mortality and length of hospital stay after coronary angiography. , 2006, Journal of the American Society of Nephrology : JASN.

[34]  George Dowswell,et al.  The initial development and assessment of an automatic alert warning of acute kidney injury. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[35]  J. Newhouse,et al.  Risk of nephropathy after intravenous administration of contrast material: a critical literature analysis. , 2006, Radiology.

[36]  G. Stone,et al.  A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. , 2004, Journal of the American College of Cardiology.

[37]  D. Bates,et al.  Improving safety with information technology. , 2003, The New England journal of medicine.

[38]  Robyn Tamblyn,et al.  Reasons for Physician Non-Adherence to Electronic Drug Alerts , 2004, MedInfo.

[39]  P. Parfrey,et al.  Clinical practice. Preventing nephropathy induced by contrast medium. , 2006, The New England journal of medicine.

[40]  Jordan J. Cohen,et al.  Hospital-Acquired Renal Insufficiency: A Prospective Study , 1983 .

[41]  Marilyn D Paterno,et al.  Electronic alerts to prevent venous thromboembolism among hospitalized patients. , 2005, The New England journal of medicine.

[42]  J. Feinglass,et al.  The epidemiology of prescribing errors: the potential impact of computerized prescriber order entry. , 2004, Archives of internal medicine.